Back
Oncternal Therapeutics Stock Predictions
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
32
ONCT
Oncternal Therapeutics
Last Price:
1.13
Seasonality Move:
21.38%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereOncternal Therapeutics Stock Forecast
-
Is Oncternal Therapeutics Stock Undervalued?
The current Oncternal Therapeutics [ONCT] share price is $1.14. The Score for ONCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - ONCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Oncternal Therapeutics Stock Go Up Next Year?
Data Unavailable
Oncternal Therapeutics Stock Rating
Data Unavailable
Oncternal Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncternal.com
52-Week Data
52-Week High:
13.14
52-Week Low:
1.05
Prediction Charts
Market Cap:
3.37M
Price in USD:
1.14
Volume:
238.24K
Beta:
1.28
Technical Analysis
SMA50:
1.74
SMA100:
3.91
SMA200:
6.38
52-Wk Change:
-81.83%
Stock Predictions
-
Is Oncternal Therapeutics stock public?
Yes, Oncternal Therapeutics is a publicly traded company. -
What is the Oncternal Therapeutics stock quote today?
The Oncternal Therapeutics stock price is 1.14 USD today. -
How to buy Oncternal Therapeutics stock online?
You can buy Oncternal Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 1.48 | 1.49 | 1.54 | 1.47 |
| Oct-28 | 1.49 | 1.44 | 1.53 | 1.38 |
| Oct-29 | 1.44 | 1.52 | 1.77 | 1.43 |
| Oct-30 | 1.53 | 1.50 | 1.60 | 1.48 |
| Oct-31 | 1.50 | 1.49 | 1.56 | 1.41 |
| Nov-1 | 1.45 | 1.50 | 1.64 | 1.43 |
| Nov-4 | 1.51 | 1.46 | 1.53 | 1.44 |
| Nov-5 | 1.51 | 1.62 | 1.68 | 1.50 |
| Nov-6 | 1.62 | 1.72 | 1.74 | 1.55 |
| Nov-7 | 1.71 | 1.37 | 1.71 | 1.26 |
| Nov-8 | 1.35 | 1.27 | 1.46 | 1.25 |
| Nov-11 | 1.33 | 1.29 | 1.33 | 1.23 |
| Nov-12 | 1.27 | 1.21 | 1.27 | 1.17 |
| Nov-13 | 1.21 | 1.14 | 1.30 | 1.03 |
Oncternal Therapeutics Earnings
Data Unavailable
Oncternal Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $1.64 per share.
* Oncternal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.